The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| NUTX | +300.69% | -14.32% | -3.04% | -98% |
| S&P | +13.22% | +85.17% | +13.11% | +49% |
Nutex Health, Inc. operates technology-enabled healthcare services. It operates through the following segments: Hospital Division, Population Health Management Division, and Real State Division. The Hospital Division is involved in developing and operating a network of micro-hospitals, specialty hospitals and hospital outpatient departments providing comprehensive and high-quality 24/7 care. The Population Health Division establishes and operates independent physician associations and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real State Division includes owning a land and hospital buildings which are leased to the hospital entities The company was founded in 2011 and is headquartered in Houston, TX.
Nutex announced it was opening its second new micro-hospital this year.
This week's bounce back is a correction to an overreaction after the company's first-quarter earnings report.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $267.80M | 239.9% |
| Gross Profit | $154.88M | 606.7% |
| Gross Margin | 57.83% | 30.0% |
| Market Cap | $573.96M | 422.1% |
| Market Cap / Employee | $0.72M | 0.0% |
| Employees | 800 | 0.0% |
| Net Income | $96.80M | 1451.0% |
| EBITDA | $135.37M | 798.8% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $166.05M | 254.0% |
| Accounts Receivable | $387.41M | 517.4% |
| Inventory | 3.2 | 39.8% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $326.07M | 15.6% |
| Short Term Debt | $32.53M | 53.4% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 17.19% | 26.1% |
| Return On Invested Capital | 99.69% | 70.6% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $99.21M | 1507.4% |
| Operating Free Cash Flow | $99.51M | 1365.7% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 3.40 | 3.70 | 12.71 | 5.36 | - |
| Price to Book | 2.73 | 1.77 | 3.49 | 2.90 | 11.99% |
| Price to Sales | 0.36 | 0.49 | 0.94 | 0.76 | 99.41% |
| Price to Tangible Book Value | 5.39 | 2.22 | 4.10 | 3.40 | -31.64% |
| Price to Free Cash Flow TTM | 8.38 | 4.37 | 8.97 | 4.21 | -23.06% |
| Enterprise Value to EBITDA | 4.41 | 7.41 | 28.17 | 7.79 | -69.62% |
| Free Cash Flow Yield | 11.9% | 22.9% | 11.2% | 23.8% | 29.97% |
| Return on Equity | 53.7% | 61.4% | 37.8% | 63.9% | -216.72% |
| Total Debt | $340.30M | $341.36M | $345.25M | $358.60M | 18.26% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
